Efficacy of Two Doses of Duloxetine and Amitriptyline in Subjects With Refractory Chronic Cough

Recruiting

Phase 2

Duloxetine & AmitriptylineEfficacy of Two Doses of Duloxetine and Amitriptyline in Subjects With Refractory Chronic Cough

Sponsor:

Mayo Clinic

Code:

NCT05110144

Conditions

Refractory Chronic Cough

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Duloxetine 30 MG

Duloxetine 60 MG

Amitriptyline 25 MG

Amitriptyline 50 MG

Placebo 30 MG

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-19. This information was provided to ClinicalTrials.gov by Mayo Clinic on 2024-04-01.